Congenica

Congenica provides an AI-powered clinical genomic interpretation platform that transforms raw sequencing data into actionable insights for rare diseases, oncology, and infectious diseases. The company serves clinical laboratories and national health programs, offering both software for variant analysis and professional clinical interpretation services. Following its acquisition by SeqOne, the platform supports germline and somatic analysis, including liquid biopsies and solid tumor profiling.